Dr. Diondra Dilworth is a science advisor in the firm’s Business Law department and a member of its Intellectual Property practice. Dr. Dilworth is a trained synthetic organic chemist and leverages this expertise to assist clients with a number of aspects related to intellectual property protections for life sciences innovations, including patent drafting, patent prosecution, prior art research, and freedom to operate analyses. She joined Goodwin in 2023.
Prior to joining Goodwin, Dr. Dilworth earned her PhD from Yale University, where she performed her doctoral research in the lab of Scott Miller. Her dissertation was done in part with the NSF C-GEM (National Science Foundation Center for Genetically Encoded Materials), where she used her synthetic organic chemistry skills to interface with the ribosome, its inputs, and its products to create novel, sequence-defined products.
Areas of Practice
American Chemical Society
National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE)
Recognition & Awards
National Science Foundation Graduate Research Fellow (NSF GRFP)